The ZMYM2–FGFR1 fusion gene has been reported to drive the development and progression of T-cell lymphoma through sustained activation of the Notch1 signaling pathway (Ren and Cowell, 2011). The gene discussed is ZMYM2; the disease is T-cell non-Hodgkin lymphoma.